Export 225 results:
Author [ Title
Filters: First Letter Of Last Name is Z [Clear All Filters]
“ABNORMAL RETINAL REFLECTIVITY TO SHORT-WAVELENGTH LIGHT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.”, Retina, vol. 38 Suppl 1, pp. S79-S88, 2018.
, “Ambient temperature and air quality in relation to small for gestational age and term low birthweight.”, Environ Res, vol. 155, pp. 394-400, 2017.
, “Ambient Temperature and Early Delivery of Singleton Pregnancies.”, Environ Health Perspect, vol. 125, no. 3, pp. 453-459, 2017.
, “Ambient Temperature and Stillbirth: A Multi-Center Retrospective Cohort Study.”, Environ Health Perspect, vol. 125, no. 6, p. 067011, 2017.
, “Ambient Volatile Organic Compounds and Racial/Ethnic Disparities in Gestational Diabetes Mellitus: Are Asian/Pacific Islander Women at Greater Risk?”, Am J Epidemiol, vol. 188, no. 2, pp. 389-397, 2019.
, “Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis.”, JAMA Netw Open, vol. 2, no. 9, p. e1910769, 2019.
, “Autologous Mesenchymal Stem Cells Produce Concordant Improvements in Regional Function, Tissue Perfusion, and Fibrotic Burden When Administered to Patients Undergoing Coronary Artery Bypass Grafting [..]”, Circ Res, vol. 114, pp. 1302-1310, 2014.
, “Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Ce”, Circ Res, vol. 114, no. 8, pp. 1302-10, 2014.
, “Baseline Patient Characteristics in the PKC-DRS2 Trial: The Effect of The PKC-b Inhibitor Ruboxistaurin on Moderate Visual Loss”, in 13th Congress of the European Society of Ophthalmology (SOE) and the 103rd Congress of German Society of Ophthalmology (DOG), Berlin, Germany, 2005.
, “BK virus is not a significant cause of graft loss in HIV+ kidney recipients (oral presentation)”, presented at the 2011, Philadelphia, PA, 2011.
, “Care cascade structural intervention versus standard of care in the diagnosis and treatment of HIV in China: a cluster-randomized controlled trial protocol.”, BMC Health Serv Res, vol. 17, no. 1, p. 397, 2017.
, “Cellular and Humoral Immunogenicity of ADMVA, a Clade C/B MVA-Based HIV-1 Candidate Vaccine, in Healthy Volunteers”, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
, “Characteristics Associated With Severe Perineal and Cervical Lacerations During Vaginal Delivery”, Obstet Gynecol, vol. 117, pp. 627-635, 2011.
, “Characteristics associated with severe perineal and cervical lacerations during vaginal delivery.”, Obstet Gynecol, vol. 117, no. 3, pp. 627-35, 2011.
, “Characterization of Reticular Drusen and Association with Age Macular Degeneration through Multiple Imaging Modalities”, in Association for Research in Vision and Ophthalmology - ARVO, Ft. Lauderdale, FL, 2012.
, “Chronic and Acute Ozone Exposure in the Week Prior to Delivery Is Associated with the Risk of Stillbirth.”, Int J Environ Res Public Health, vol. 14, no. 7, 2017.
, “Clinical and Genomic Analysis of Metastatic Disease Progression in a Background of Biochemical Recurrence”, in 2012 ASTRO - American Society for Radiation Oncology, Boston, MA, 2012.
, “Clinical trials referral resource. Clinical trials with perillyl alcohol.”, Oncology (Williston Park), vol. 11, no. 12, p. 1817, 1820, 1997.
, “Clinical trials referral resource. Current clinical trials of bortezomib.”, Oncology (Williston Park), vol. 17, no. 5, pp. 677-80, 683-6, 691-2, 2003.
, “Clinical trials referral resource. Current clinical trials of fenretinide.”, Oncology (Williston Park), vol. 15, no. 12, pp. 1595-6, 1598, 1600, 2001.
, “Clinical trials referral resource. Current clinical trials of G3139.”, Oncology (Williston Park), vol. 17, no. 9, pp. 1244-6, 1251-3, 1258, 2003.
, “Clinical trials referral resource. Current clinical trials of molecularly targeted agents in children with cancer, Part 2.”, Oncology (Williston Park), vol. 16, no. 4, pp. 474, 479-80, 483-4 passim, 2002.
, “Clinical trials referral resource. Current clinical trials of R115777 (Zarnestra).”, Oncology (Williston Park), vol. 16, no. 7, pp. 930-1, 935-7, 2002.
, “Clinical Trials Referral Resource. Current Phase III Breast Cancer Clinical Trials”, Oncology (Williston Park), vol. 20, p. 696, 700, 702, 2006.
,